New + Emerging Treatments
The New + Emerging Treatments program series is hosted annually by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long webinar is dedicated to a specific subtype of leukemia, and addresses the latest treatments and what's on the horizon, followed by a live Q + A.
The 2024 virtual webinar series was held Tuesday, June 11 and Wednesday, June 12. Links to recordings for each program are included below.
Chronic lymphocytic leukemia (CLL)
Tuesday, June11, 2024 i 7:00PM-8:00PM CT (5-6 PT, 6-7 MT, 8-9 ET)
Farrukh T. Awan, MD, from the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, discusses current CLL treatments and what new treatments are on the horizon.
Chronic myeloid leukemia (CML)
TUESDAY, JUNE 11, 2024 I 8:00-9:00 CT (6-7 PT, 7-8 MT, 9-10 ET)
Gabriela Hobbs, MD, Clinical Director of the Adult Leukemia Service Program, from Massachusetts General Hospital, addresses current CML treatments and shares what new treatments are on the horizon.
Wednesday, JUNE 12, 2024 I 7:00-8:00PM CT (5-6 PT, 6-7 MT, 8-9 ET)
Shira N. Dinner, MD, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Feinberg School of Medicine, discusses current ALL treatments and what new treatments are on the horizon.
Acute myeloid leukemia (AML)
Wednesday, June 12, 2024 | 8:00-9:00pm CT (6-7 PT, 7-8 MT, 9-10 ET)
Matt Christopher, MD, PhD, from the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, addresses current AML treatments and shares what new treatments are on the horizon.
Program supporters
